The U.S. government has awarded Novavax Inc $1.6 billion to cover testing and manufacturing of a potential vaccine

China is forging ahead in the race to develop a vaccine to help control the COVID-19 pandemic, with Sinovac Biotech’s experimental vaccine

California, another epicenter, saw positive tests climb 37% with hospitalizations up 56% over the past two weeks.